Chief executive of Novo Nordisk since August 2025, succeeding Lars Fruergaard Jørgensen, who was ousted by the board. Previously head of Novo's non-American business. Mr Doustdar has said he wants Novo to build a "consumer mindset" and think "more like Amazon", offering customers the speed and flexibility they now expect. He is pushing a new generation of obesity treatments while making sweeping changes to how the company operates, including expanding direct-to-consumer sales channels and striking retail partnerships with Costco and Walmart.
Give me a sleeping pill and tell me your troubles.